Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, T-Cell, Cutaneous × liposomal doxorubicin × 1 year × Clear all

Sponsor

Conditions

Ovarian Neoplasms 16 Fallopian Tube Neoplasms 11 Breast Neoplasms 9 Triple Negative Breast Neoplasms 5 Carcinoma, Ovarian Epithelial 5 Sarcoma 3 Sarcoma, Kaposi 2 Sarcoma, Ewing 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Neoplasms 2 Neoplasm Metastasis 2 Multi-centric Castleman's Disease 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma, B-Cell 2 Hodgkin Disease 2 Burkitt Lymphoma 2 Acquired Immunodeficiency Syndrome 2 AIDS-related Kaposi sarcoma 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Vaccinia 1 Uterine Cervical Neoplasms 1 Rhabdomyosarcoma 1 Recurrent Epithelial Ovarian, Fallopian or Peritoneal Carcinoma 1 Recurrence 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Osteosarcoma 1 Multiple Myeloma 1 Macular dystrophy, corneal type 1 1

Interventions

Cyclophosphamide 7 Biopsy 6 romidepsin 5 mogamulizumab 5 fludarabine 5 Brentuximab Vedotin 5 pembrolizumab 4 fludarabine phosphate 4 Specimen Handling 4 Magnetic Resonance Spectroscopy 4 Immunoglobulin G 4 Disulfides 4 ruxolitinib 3 Peripheral Blood Stem Cell Transplantation 3 Nivolumab 3 Mycophenolic Acid 3 Lenalidomide 3 Depsipeptides 3 hypericin 2 belinostat 2 Whole-Body Irradiation 2 Tacrolimus 2 Melphalan 2 Lactones 2 Etoposide 2 Busulfan 2 Bexarotene 2 trastuzumab biosimilar HLX02 1 tofacitinib 1 thymoglobulin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡